Agios Pharmaceuticals chief medical officer Sarah Gheuens reports sale of $74,642.17 in common shares
AGIO•Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens sold 1,989 common shares for about $74,642 across October 21 and 22, 2026, and exercised options for the same number of shares at $25.01 each.
1. Share transactions
Gheuens sold 1,489 common shares at $37.53 on October 21, 2026, and 500 shares at $37.52 the following day. She exercised stock options for 1,989 common shares at $25.01 per share across the two dates. After the transactions, she directly held 54,645 common shares and 24,141 stock options.
